Trial
NCT04523090
Catalysing the Containment of COVID-19
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Cape Town
Collaborators
Medical Research Council, South Africa; Aurum Institute; National Institutes of Health (NIH); Texas Tech University Health Sciences Center; University of KwaZulu; Perinatal HIV Research Unit of the University of the Witswatersrand
Condition
COVID-19
Intervention
Nitazoxanide
Why stopped
Signal of futility at interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-16